by Anna Megdell, University of Michigan Credit: Jacques Nor Researchers at the University of Michigan Rogel Cancer Center and School of Dentistry found that certain drugs can change the fundamental makeup of cancer stem cells in mouse models of mucoepidermoid carcinoma—a lethal form of salivary gland cancer that currently has no treatment options. These results...
Discovery in the NCI-MATCH precision medicine cancer trial is consistent with another recent trial, signaling that the data on ado-trastuzumab (T-DM1) is promising for this rare cancer ECOG-ACRIN CANCER RESEARCH GROUP The antibody-drug conjugate ado-trastuzumab emtansine (T-DM1) has promising activity in HER2 amplified salivary gland tumors, according to data published in the Annals of Oncology....
